BioScience Health Innovations, Inc. (BHIC)
| Market Cap | 72.75M |
| Revenue (ttm) | 5.69M +208.3% |
| Net Income | 642.09K +638.0% |
| EPS | 0.06 +604.8% |
| Shares Out | 11.37M |
| PE Ratio | 109.43 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,800 |
| Average Volume | 4,521 |
| Open | 3.66 |
| Previous Close | 4.30 |
| Day's Range | 3.66 - 6.40 |
| 52-Week Range | 0.52 - 6.40 |
| Beta | 0.63 |
| RSI | 58.23 |
| Earnings Date | May 5, 2026 |
About BHIC
BioScience Health Innovations, Inc. distributes clinically tested and affordably priced products to battle the onslaught of bacteria and viruses in the United States. The company markets Be On-Guard Mouth Spray and Nasal Spray; EZ Safer Surface Cleaner; Be On-Guard brain fog support; Active Daily Health Defence 365 for maximum strength brain support; NeuroPro Plus, a patent pending combination of pharmaceutical grade methylene blue and vitamin; TBI-365 to elevate brain health and wellness with pharmaceutical grade methylene blue, glucine, nac a... [Read more]
Financial Performance
In 2025, BHIC's revenue was $5.69 million, an increase of 208.34% compared to the previous year's $1.84 million. Earnings were $642,090, an increase of 638.03%.
Financial StatementsNews
Rebelution Partners with Best 365 Labs and Growvana to Scale Science-Backed Cellular Health on Amazon and Beyond
Pioneering NAD and Mitochondrial Optimization Company Taps Rebelution E-Commerce's Infrastructure to Deliver Affordable, Ground-Zero Natural Health and Wellness to Everyone. CHICAGO, March 12, 2026 /P...